Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans
- PMID: 15679664
- DOI: 10.1111/j.1439-0507.2004.01052.x
Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans
Abstract
We reassessed the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against the pathogenic yeast Candida albicans. No synergistic effect of fluconazole combined with ibuprofen was seen against fluconazole-susceptible strains, but a remarkable effect was seen against fluconazole-resistant strains (FIX index: 0.02-0.03). Furthermore, vigorous growth of the microorganism, the so-called 'Eagle effect', was observed at concentrations higher than the minimal inhibitory concentrations of ibuprofen and fluconazole. Our results suggest that the combination of ibuprofen and fluconazole should prove useful for treating infection caused by fluconazole-resistant C. albicans.
Similar articles
-
Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.FEMS Yeast Res. 2009 Jun;9(4):618-25. doi: 10.1111/j.1567-1364.2009.00504.x. Epub 2009 Mar 30. FEMS Yeast Res. 2009. PMID: 19416368
-
The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.FEMS Yeast Res. 2010 Nov;10(7):885-93. doi: 10.1111/j.1567-1364.2010.00664.x. Epub 2010 Aug 12. FEMS Yeast Res. 2010. PMID: 20707818
-
Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.Antimicrob Agents Chemother. 2006 Mar;50(3):1096-9. doi: 10.1128/AAC.50.3.1096-1099.2006. Antimicrob Agents Chemother. 2006. PMID: 16495278 Free PMC article.
-
Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery.Int J Antimicrob Agents. 2014 May;43(5):395-402. doi: 10.1016/j.ijantimicag.2013.12.009. Epub 2014 Jan 22. Int J Antimicrob Agents. 2014. PMID: 24503221 Review.
-
Population dynamics and the evolution of antifungal drug resistance in Candida albicans.FEMS Microbiol Lett. 2012 Aug;333(2):85-93. doi: 10.1111/j.1574-6968.2012.02587.x. Epub 2012 May 21. FEMS Microbiol Lett. 2012. PMID: 22540673 Review.
Cited by
-
Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal.Microorganisms. 2020 Jan 22;8(2):154. doi: 10.3390/microorganisms8020154. Microorganisms. 2020. PMID: 31979032 Free PMC article. Review.
-
Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection?Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):59-75. doi: 10.1007/s00210-023-02651-x. Epub 2023 Aug 17. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37589736 Review.
-
Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole.Mycopathologia. 2012 Sep;174(3):215-21. doi: 10.1007/s11046-012-9538-7. Epub 2012 Apr 22. Mycopathologia. 2012. PMID: 22528740
-
Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):127-31. doi: 10.1007/s10096-007-0411-4. Epub 2007 Dec 4. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18057972
-
Novel aza-bicyclic 2-isoxazoline acylhydrazone hybrids and their synergistic potential with fluconazole against a drug-resistant Candida albicans strain.Braz J Microbiol. 2024 Jun;55(2):1811-1816. doi: 10.1007/s42770-024-01325-x. Epub 2024 May 13. Braz J Microbiol. 2024. PMID: 38739216 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources